A new approach to drug design can deliver medicine directly to the gut in mice at significantly lower doses than current inflammatory bowel disease treatments.
The proof-of-concept study, published today in Science, introduced a mechanism called…
A digestive ‘treasure chest’ shows promise for targeted drug treatment in the gut
